Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0YD9E
|
||||
Former ID |
DIB006988
|
||||
Drug Name |
PF-00212062
|
||||
Synonyms |
EP2 antagonists, Pfizer; PF-00212062; PF-04852946
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543187] | ||
Company |
Pfizer Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C27H24N2O5
|
||||
InChI |
InChI=1S/C27H24N2O5/c1-33-23-10-8-22(9-11-23)25(30)29-15-14-27(17-29,26(31)32)18-34-24-12-6-21(7-13-24)20-4-2-19(16-28)3-5-20/h2-13H,14-15,17-18H2,1H3,(H,31,32)
|
||||
InChIKey |
MDVYCLAYSVNYDS-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Prostaglandin E2receptor, EP2 subtype | Target Info | Antagonist | [543778] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.